Kelly A. Shipkowski, Ph.D., D.A.B.T.

Office of Program Operations

Image

Kelly A. Shipkowski, Ph.D., D.A.B.T., is a Health Science Evaluator in the Office of Program Operations (OPO) in the Division of Translational Toxicology (DTT). Shipkowski is a contracting officer’s representative and administers and monitors contracts for scientific information management and literature-based evaluations, data extraction, and in vitro and in vivo toxicity studies. She also supports the design, conduct, interpretation, and reporting of studies evaluating the toxicity and carcinogenicity of chemicals of human health concern. Additionally, she serves as a project leader for NTP and DTT studies of metals and other potentially hazardous environmental exposures.

Shipkowski received a B.S. in both biology and chemistry from Methodist University in 2010 and a Ph.D. in toxicology from North Carolina State University in 2015. Following completion of her Ph.D., she worked as an intramural research training award (IRTA) postdoctoral fellow at DTT. Prior to joining OPO in 2020, she worked as a lead toxicologist at ICF, a global consulting firm.